1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
File Format:  Adobe PDF
Type:  Article

Results 1-20 of 67 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
11-Aug-20223-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET PredictionRamalingam, Arulraj ; Mustafa, Nurulhuda ; Chng, Wee Joo ; Medimagh, Mouna; Sambandam, Sivakumar; Issaoui, Noureddine
220-Jun-2022A genomic-augmented multivariate prognostic model for the survival of Natural-killer/T-cell lymphoma patients from an international cohort.Lim, Jing Quan ; Huang, Dachuan ; Chan, Jason Yongsheng; Laurensia, Yurike; Wong, Esther Kam Yin; Cheah, Daryl Ming Zhe; Chia, Burton Kuan Hui; Chuang, Wen-Yu; Kuo, Ming-Chung; Su, Yi-Jiun; Cai, Qing-Qing; Feng, Yanfen; Rao, Huilan; Feng, Li-Na; Wei, Pan-Pan; Chen, Jie-Rong; Han, Bo-Wei; Lin, Guo-Wang; Cai, Jun; Fang, Yu; Tan, Jing; Hong, Huangming; Liu, Yanhui; Zhang, Fen; Li, Wenyu; Poon, Michelle LM; Ng, Siok-Bian ; Jeyasekharan, Anand ; Ha, Jeslin Chian Hung; Khoo, Lay Poh; Chin, Suk Teng; Pang, Wan Lu; Kee, Rebecca; Cheng, Chee Leong ; Grigoropoulos, Nicholas Francis; Tang, Tiffany; Tao, Miriam; Farid, Mohamad ; Puan, Kia Joo; Xiong, Jie; Zhao, Wei-Li; Khor, Chiea Chuen ; Hwang, William; Kim, Won Seog; Campo, Elias; Tan, Patrick ; Teh, Bin Tean ; Chng, Wee-Joo ; Rötzschke, Olaf; Tousseyn, Thomas; Huang, Hui-Qiang; Rozen, Steve; Lim, Soon Thye ; Shih, Lee-Yung; Bei, Jin-Xin; Ong, Choon Kiat 
315-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
41-Dec-2023A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myelomaChng, WJ ; Lonial, S; Morgan, GJ; Iida, S; Moreau, P; Kumar, SK; Twumasi-Ankrah, P; Villarreal, M; Dash, AB; Vorog, A; Zhang, X; Suryanarayan, K; Labotka, R; Dimopoulos, MA; Rajkumar, SV
51-Jun-2021A unique rhinologic manifestation of multiple myelomaSeah, Jun Jie; Chng, Wee Joo ; Thong, Mark Kim Thye
61-Mar-2011Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingNg, Siok-Bian ; Selvarajan, Viknesvaran; Huang, Gaofeng; Zhou, Jianbiao ; Feldman, Andrew L; Law, Mark; Kwong, Yok-Lam; Shimizu, Norio; Kagami, Yoshitoyo; Aozasa, Katsuyuki; Salto-Tellez, Manuel; Chng, Wee-Joo 
71-Sep-2020ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.Zhou, Jianbiao ; Yiying Quah, Jessie ; Ng, Yvonne ; Chooi, Jing-Yuan ; Hui-Min Toh, Sabrina ; Lin, Baohong; Zea Tan, Tuan ; Hosoi, Hiroki ; Osato, Motomi ; Seet, Qihui; Ooi, Lisa AG; Lindmark, Bertil; McHale, Mark; Chng, Wee-Joo 
81-Jan-2016Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligenceAbid, Muhammad Bilal; De Mel, Sanjay; Abid, Muhammad Abbas; Tan, Kong Bing; Chng, Wee Joo 
91-Jun-2017Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORChng, W-J ; Goldschmidt, H; Dimopoulos, MA; Moreau, P; Joshua, D; Palumbo, A; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Feng, S; Aggarwal, S; Hajek, R
1016-Aug-2021Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequencesCao, Fan ; Zhang, Yu; Cai, Yichao; Animesh, Sambhavi; Zhang, Ying; Akincilar, Semih Can; Loh, Yan Ping; Li, Xinya; Chng, Wee Joo ; Tergaonkar, Vinay ; Kwoh, Chee Keong; Fullwood, Melissa J 
111-Aug-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaMadan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
121-Dec-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)Madan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
1321-Sep-2023COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore A Nationwide Cohort StudyTan, Wei Chong; Tan, Janice Yu Jin; Lim, Joline Si Jing ; Tan, Ryan Ying Cong ; Lee, Ainsley Ryan Yan Bin; Leong, Fun Loon; Lee, Soo Chin ; Chai, Louis Yi Ann ; Tan, Thuan Tong ; Malek, Muhammad Ismail Bin Abdul; Ong, Benjamin ; Lye, David Chien ; Chiew, Calvin J; Chng, Wee Joo ; Lim, Soon Thye ; Bharwani, Lavina D; Tan, Iain Beehuat; Sundar, Raghav ; Tan, Kelvin Bryan
1416-Oct-2021DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypesKizhakeyil, Atish; Zaini, Nurmahirah Binte Mohammed; Poh, Zhi Sheng; Wong, Brandon Han Siang; Loh, Xinpeng; Ng, Aik Seng; Low, Zun Siong; Prasannan, Praseetha; Gong, Chun; Tan, Michelle Guet Khim; Nagarajan, Chandramouli; Huang, Dachuan; Lu, Pang Wan; Lim, Jing Quan; Barrans, Sharon; Ong, Choon Kiat; Lim, Soon Thye; Chng, Wee Joo ; Follows, George; Hodson, Daniel J; Du, Ming Qing; Goh, Yeow Tee; Tan, Suat Hoon; Grigoropoulos, Nicholas Francis; Verma, Navin Kumar
1523-Apr-2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A; Rajkumar, S Vincent; Weisel, Katja C; Moreau, Philippe; Chng, Wee-Joo ; Mikala, Gabor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Victoria Mateos, Maria
1610-Jun-2020Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup AnalysisHuang, Shang-Yi; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chng, Wee Joo ; Chang, Cheng-Shyong; Wong, Raymond Siu-Ming; Gao, Seasea; Wang, Yang; Gordon, Steve W; Glennane, Anthony; Min, Chang-Ki
171-Jan-2021Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaMustafa, Nurulhuda ; Nee, Adina Huey Fang ; Chooi, Jing Yuan ; Toh, Sabrina Hui Min ; Chung, Tae-Hoon ; Selvarajan, Viknesvaran ; Fan, Shuangyi ; Ng, Siok Bian ; Poon, Michelle ; Chan, Esther ; Lee, Joanne; Chee, Yen Lin ; Jeyasekharan, Anand D ; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo 
183-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo 
191-Sep-2021Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsLee, Wen-Hsin Sandy; Ye, Zhiyong; Cheung, Alice MS; Goh, YP Sharon; Oh, Hsueh Ling Janice; Rajarethinam, Ravisankar; Yeo, Siok Ping; Soh, Mun Kuen; Li Chan, Esther Hian; Tan, Lip Kun; Tan, Soo-Yong ; Chuah, Charles ; Chng, Wee Joo ; Connolly, John E; Wang, Cheng-I
201-Feb-2012Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in MiceGuo, Ke; Tang, Jing Ping ; Jie, Li; Al-Aidaroos, Abdul Qader O; Hong, Cheng William; Tan, Cheng Peow Bobby; Park, Jung Eun; Varghese, Leyon; Feng, Zhiwei; Zhou, Jianbiao; Chng, Wee Joo ; Zeng, Qi